Progyny, Inc.
General ticker "PGNY" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $1.8B (TTM average)
Progyny, Inc. follows the US Stock Market performance with the rate: 18.5%.
Estimated limits based on current volatility of 2.0%: low 24.24$, high 25.24$
Factors to consider:
- Total employees count: 680 (+20.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Customer relationships, Economic downturns and volatility
- Current price 12.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.42$, 21.52$]
- 2025-12-31 to 2026-12-31 estimated range: [9.60$, 19.58$]
Financial Metrics affecting the PGNY estimates:
- Positive: with PPE of 9.3 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 5.78
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 6.82 < Operating cash flow per share per price, % of 12.78
Short-term PGNY quotes
Long-term PGNY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $786.91MM | $1,088.60MM | $1,167.22MM |
| Operating Expenses | $763.57MM | $1,026.41MM | $1,099.77MM |
| Operating Income | $23.34MM | $62.18MM | $67.45MM |
| Non-Operating Income | $1.10MM | $8.51MM | $15.75MM |
| Income(Loss) | $24.44MM | $70.69MM | $83.20MM |
| Taxes | $-5.92MM | $8.65MM | $28.87MM |
| Profit(Loss)* | $30.36MM | $62.04MM | $54.34MM |
| Stockholders Equity | $376.97MM | $553.43MM | $422.06MM |
| Assets | $542.99MM | $756.62MM | $607.10MM |
| Operating Cash Flow | $80.39MM | $188.81MM | $179.10MM |
| Capital expenditure | $3.24MM | $3.64MM | $5.41MM |
| Investing Cash Flow | $-43.87MM | $-200.53MM | $195.79MM |
| Financing Cash Flow | $-7.86MM | $-11.07MM | $-309.88MM |
| Earnings Per Share** | $0.33 | $0.65 | $0.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.